clinical trial · NCT06868628
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Multiple System AtrophyForalumab Nasal
brief summary
A Phase 2a Study of Foralumab Nasal in Patients with Multiple System Atrophy (MSA)
started
May 19, 2025
primary completion
Apr 1, 2027
completion
Apr 1, 2027
last updated
Sep 23, 2025
official title
A Phase 2a Study to Evaluate Microglial Activation, Safety, and Clinical Effects of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol